Suppr超能文献

经皮冠状动脉慢性完全闭塞血运重建后交叉策略对中期结果的影响。

Impact of crossing strategy on midterm outcomes following percutaneous revascularisation of coronary chronic total occlusions.

机构信息

Interventional Cardiology, San Raffaele Scientific Institute, Milan, Italy.

出版信息

EuroIntervention. 2017 Oct 20;13(8):978-985. doi: 10.4244/EIJ-D-16-01010.

Abstract

AIMS

The aim of the present study was to compare the midterm clinical outcomes of patients undergoing successful chronic total occlusion (CTO) percutaneous coronary intervention (PCI) according to the crossing technique used, in a large multicentre registry.

METHODS AND RESULTS

We compiled a multicentre registry of consecutive patients undergoing successful CTO PCI. Patients were divided into three groups: true-to-true (TTT) approach, modern dissection/re-entry (DR) techniques (CrossBoss/Stingray, reverse CART), and old DR techniques (LAST, STAR, CART). Cox regression was used to identify independent predictors of major adverse cardiac events (MACE: cardiac death, myocardial infarction and target vessel revascularisation). We included 924 patients (TTT, n=571; modern DR, n=258; old DR, n=95). Patients in both DR groups had a higher prevalence of comorbidities, angiographic and procedural complexity. The 12-month MACE rate was higher in old DR (22.1%) than in modern DR (8.9%) and TTT (9.1%, p<0.001). Old (hazard ratio [HR] 2.02, 95% confidence interval [CI]: 1.12 to 3.61, p=0.02) but not modern (HR 0.98, 95% CI: 0.54 to 1.79, p=0.96) DR techniques were associated with a higher adjusted risk of MACE compared to TTT.

CONCLUSIONS

The use of old but not modern DR techniques was associated with a higher risk of MACE. Therefore, CrossBoss/Stingray and reverse CART might be considered as first-line strategies for antegrade and retrograde DR-based CTO PCI, respectively.

摘要

目的

本研究旨在比较在大型多中心注册研究中,根据使用的交叉技术,成功进行慢性完全闭塞(CTO)经皮冠状动脉介入治疗(PCI)的患者的中期临床结果。

方法和结果

我们汇编了一项连续成功进行 CTO PCI 的多中心注册研究。患者分为三组:真到真(TTT)方法、现代解剖/再进入(DR)技术(CrossBoss/Stingray、逆向 CART)和旧 DR 技术(LAST、STAR、CART)。使用 Cox 回归确定主要不良心脏事件(MACE:心脏死亡、心肌梗死和靶血管血运重建)的独立预测因素。我们纳入了 924 名患者(TTT,n=571;现代 DR,n=258;旧 DR,n=95)。DR 两组患者的合并症、血管造影和手术复杂性发生率均较高。12 个月 MACE 发生率在旧 DR 组(22.1%)高于现代 DR 组(8.9%)和 TTT 组(9.1%)(p<0.001)。旧 DR 技术(风险比[HR]2.02,95%置信区间[CI]:1.12 至 3.61,p=0.02)而非现代 DR 技术(HR 0.98,95%CI:0.54 至 1.79,p=0.96)与 TTT 相比,与 MACE 风险增加相关。

结论

使用旧而非现代 DR 技术与 MACE 风险增加相关。因此,CrossBoss/Stingray 和逆向 CART 可能分别被视为正向和逆向基于 DR 的 CTO PCI 的一线策略。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验